Table 3.
Multivariable analyses of risk prediction scores after 1 year of ursodeoxycholic acid therapy
|
|
Univariate analyses
|
Multivariable analyses
|
||||
|
Prognostic score
|
Hazard ratio
|
95%CI
|
P value
|
Hazard ratio
|
95%CI
|
P value
|
| GLOBE | 1.703 | 1.474-1.967 | < 0.001 | 1.582 | 1.029-2.433 | 0.037 |
| UK-PBC | 6.046 | 3.479-10.510 | < 0.001 | 1.012 | 0.330-3.102 | 0.983 |
| APRI | 0.998 | 0.971-1.024 | 0.860 | 0.918 | 0.812-1.038 | 0.171 |
| FIB4 | 1.005 | 0.997-1.013 | 0.242 | 1.008 | 0.991-1.024 | 0.369 |
| ALBI | 2.546 | 1.955-3.316 | < 0.001 | 1.194 | 0.595-2.40 | 0.618 |
| Mayo | 1.495 | 1.348-1.676 | < 0.001 | 1.022 | 0.697-1.497 | 0.913 |
ALBI: Albumin-bilirubin; APRI: Aspartate aminotransferase-to-platelet ratio index; CI: Confidence interval; FIB4: Fibrosis-4 index.